In August 1650, 15 women and one man were publicly executed on Newcastle's Town Moor, with their bodies then buried in ...

PCM Trials, along with its subsidiaries EmVenio Research and Clinical Trial Service, are aligning under a single name – ...

Victorian brain cancer researchers have achieved a global-first, using an innovative process to learn how a new drug ...

By Rishika Sadam and Bhanvi Satija (Reuters) -Japanese drugmaker Takeda Pharmaceutical is exploring the option of conducting ...

Under brand names like Ozempic and Wegovy, semaglutide-based medications have made a significant difference in treating type ...

To find out how FDA’s new draft guidance, Oncology Therapeutic Radiopharmaceuticals: Dosage Optimization During Clinical ...

Russian Kirov-class nuclear-powered cruiser Admiral Nakhimov commenced sea trials on 18 August 2025 following a lengthy ...

For decades, dentists and scientists have dreamed of helping people regrow lost teeth. Now, thanks to remarkable advances in ...

Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an oncology-focused life sciences company developing innovative therapies based on its uniquely biocompatible gold nanorod ...

U.S. and China regulators have now cleared Sineugene Therapeutics' ALS gene therapy SNUG01 for clinical trials.

For years, scientists have hoped to harness the immune system to attack cancer using a group of drugs known as CD40 agonist ...